These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Utility-based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha-fetoprotein model as a survival predictor. Vitale A, Farinati F, Burra P, Trevisani F, Giannini EG, Ciccarese F, Piscaglia F, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Borzio F, Cabibbo G, Felder M, Sacco R, Morisco F, Missale G, Foschi FG, Gasbarrini A, Svegliati Baroni G, Virdone R, Chiaramonte M, Spolverato G, Cillo U, Italian Liver Cancer Group. Liver Transpl; 2015 Oct; 21(10):1250-8. PubMed ID: 26183802 [Abstract] [Full Text] [Related]
11. Delta-slope of alpha-fetoprotein improves the ability to select liver transplant patients with hepatocellular cancer. Lai Q, Inostroza M, Rico Juri JM, Goffette P, Lerut J. HPB (Oxford); 2015 Dec; 17(12):1085-95. PubMed ID: 26373980 [Abstract] [Full Text] [Related]
16. Outcome of liver transplantation for hepatocellular carcinoma -- a single center experience. Iacob R, Iacob S, Gheorghe L, Gheorghe C, Hrehoreţ D, Brașoveanu V, Croitoru A, Herlea V, Popescu I. Chirurgia (Bucur); 2013 Dec; 108(4):446-50. PubMed ID: 23958083 [Abstract] [Full Text] [Related]